WPD Pharmaceuticals Inc. (CSE: WBIO)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Nov 18, 2024, 9:30 AM EST
WPD Pharmaceuticals Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cost of Revenue | - | - | 0.02 | 0.1 | 0.11 | 0.11 | Upgrade
|
| Gross Profit | - | - | -0.02 | -0.1 | -0.11 | -0.11 | Upgrade
|
| Selling, General & Admin | 0.29 | 0.23 | 2.16 | 5.49 | 2.93 | 1.16 | Upgrade
|
| Research & Development | - | - | - | -0 | 0.46 | 0.1 | Upgrade
|
| Other Operating Expenses | - | - | 0.02 | 0.07 | 0.08 | - | Upgrade
|
| Operating Expenses | 0.31 | 0.23 | 2.25 | 6 | 8.25 | 3.32 | Upgrade
|
| Operating Income | -0.31 | -0.23 | -2.27 | -6.1 | -8.36 | -3.43 | Upgrade
|
| Interest Expense | -0.06 | -0.03 | -0.17 | -0.09 | -0.02 | -0.06 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.01 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | 0.01 | -0.01 | -0.2 | 0.09 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | -0.02 | 1.82 | 0.97 | 1.21 | 1.09 | Upgrade
|
| EBT Excluding Unusual Items | -0.43 | -0.28 | -0.63 | -5.42 | -7.07 | -2.45 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -9.73 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.22 | 0.22 | - | - | -0.48 | 0.48 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 4.52 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -0.03 | -0.44 | - | - | Upgrade
|
| Other Unusual Items | 0.06 | -0.03 | - | 0.23 | 0.03 | 0.09 | Upgrade
|
| Pretax Income | -0.14 | -0.08 | 3.86 | -5.62 | -7.52 | -11.61 | Upgrade
|
| Net Income | -0.14 | -0.08 | 3.86 | -5.62 | -7.52 | -11.61 | Upgrade
|
| Net Income to Common | -0.14 | -0.08 | 3.86 | -5.62 | -7.52 | -11.61 | Upgrade
|
| Shares Outstanding (Basic) | 114 | 113 | 113 | 113 | 113 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 114 | 113 | 113 | 113 | 113 | 3 | Upgrade
|
| Shares Change (YoY) | 0.08% | - | - | 0.28% | 3211.13% | - | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | 0.03 | -0.05 | -0.07 | -3.40 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | 0.03 | -0.05 | -0.07 | -3.40 | Upgrade
|
| Free Cash Flow | -0.19 | -0.21 | -3.43 | -1.49 | -1.44 | -0.17 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.03 | -0.01 | -0.01 | -0.05 | Upgrade
|
| EBITDA | -0.31 | -0.23 | -2.25 | -5.82 | -8.03 | -3.39 | Upgrade
|
| D&A For EBITDA | -0 | 0 | 0.02 | 0.28 | 0.33 | 0.04 | Upgrade
|
| EBIT | -0.31 | -0.23 | -2.27 | -6.1 | -8.36 | -3.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.